Outcome of STEMI Fast Pass System Development in Chiangrai – Phayoa Cardiac Network
Article Sidebar
Main Article Content
Abstract
Objective
To study Door-to-Balloon time (DTB time) and In-hospital mortality rate after use STEMI Fast Pass System.
Method
Retrospective descriptive study of acute ST elevation myocardial infarction (STEMI) patients who were referred to Chiangraiprachanukroh Hospital (CRH) for primary percutaneous coronary intervention (Primary PCI). STEMI Fast Track System used from 1 October 2017 – 30 September 2019. STEMI Fast Pass System used from 1 October 2019 – 30 September 2020.
Result
There were 82 patients in STEMI Fast Track System and 90 patients in STEMI Fast Pass System. Most of them were male and mean age was 65 years old. The underlying diseases and the complications before primary PCI were similar except STEMI Fast Pass System had more cardiac arrest need CPR than STEMI Fast Track System (22.2% vs. 9.7%, P=0.038). Anti-platelet, anti-coagulant and beta-blocker were not different among 2 groups but STEMI Fast Pass System use glycoprotein IIb/IIIa (42.2% vs. 24.3%, P=0.016), ACEi/ARB (34.4% vs. 12.2%, P=0.001) and high potency statin (86.6% vs. 64.6%, P=0.001) higher than STEMI Fast Track System. The Fast Pass System had lower door-to-balloon time (DTB time) from 82.6 to 44.1 minutes (P<0.001) and lower in-hospital mortality than the Fast Track System (13.4% vs. 18.3%, P=0.407).
Conclusion
STEMI Fast Pass had shorter DTB time statistically significant and had lower in-hospital mortality than STEMI Fast Track System
Keywords
ST Elevation Myocardial Infarction, Acute coronary syndrome, Fast Track,
Door-to-balloon time, Primary percutaneous coronary intervention
Article Details
References
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ,Cushman M, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322.
McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011;124(1):40-7.
Srimahachota S, Kanjanavanit R, Boonyaratavej S, Boonsom W, Veerakul G, Tresukosol D, et al. Demographic, management practices and in-hospital outcomes of Thai Acute Coronary Syndrome Registry (TACSR): the difference from the Western world. J Med Assoc Thai. 2007;90 Suppl 1:1-11.
Srimahachota S, Kanjanavanit R, Boonyaratavej S, Boonsom W, Veerakul G, Tresukosol D, et al. Demographic, management practices and in-hospital outcomes of Thai Acute Coronary Syndrome Registry (TACSR): the difference from the Western world. J Med Assoc Thai. 2007;90(Suppl 1):1-11.
Srimahachota S, Boonyaratavej S, Kanjanavanit R, Sritara P, Krittayaphong R, Kunjara-Na-ayudhya R, et al. Thai Registry in Acute Coronary Syndrome (TRACS)--an extension of Thai Acute Coronary Syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year. J Med Assoc Thai. 2012;95(4):508-18.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77.
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of cardiology(ESC ). Eur Heart J. 2018;39(2):119-77.
De Luca G, Suryapranata H, Zijlstra F, van 't Hof AW, Hoorntje JC, Gosselink AT, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003;42(6):991-7.
De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109(10):1223-5.
Mefford MT, Li BH, Qian L, Reading SR, Harrison TN, Scott RD, et al. Sex-Specific Trends in Acute Myocardial Infarction Within an Integrated Healthcare Network, 2000 Through 2014. Circulation. 2020;141(7):509-19.
Mefford MT, Li BH, Qian L, Reading SR, Harrison TN, Scott RD, et al. Sex-Specific trends in acute myocardial infarction within an integrated healthcare network, 2000 through . Circulation. 2020;141(7):509-19.
Neumann JT, Gossling A, Sorensen NA, Blankenberg S, Magnussen C, Westermann D. Sex-Specific Outcomes in Patients with Acute Coronary Syndrome. J Clin Med. 2020;9(7).
Neumann JT, Gossling A, Sorensen NA, Blankenberg S, Magnussen C, Westermann D. Sex differences in patients with acute coronary syndrome. J Clin Med. 2020;9(7):2124.
Gersh BJ, Stone GW, White HD, Holmes DR, Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA. 2005;293(8):979-86.
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20.
